3023042-32-9
3023042-32-9
Chemical Structure
SARS-CoV-2 3CLpro-IN-35
- CAS No.: 3023042-32-9
- Formula:C32H24F6O6
- Molecular Weight:618.52
InChIKey: MLZFWLHYTRXIJE-UHFFFAOYSA-N
SMILES: O=C(CCC1=CC(C2=CC=C(C=C2)C(F)(F)F)=C(C(C3=C(C(C4=CC=C(C=C4)C(F)(F)F)=CC(CCC(O)=O)=C3)O)=C1)O)O
Biological Activity: SARS-CoV-2 3CLpro-IN-35 is a SARS-CoV-2 3CLpro inhibitor with an IC50 of 0.15 μM. SARS-CoV-2 3CLpro-IN-35 inhibits the proliferation of bladder cancer cells, exerts anti-SARS-CoV-2 activity, and exhibits low cytotoxicity in fibroblasts. SARS-CoV-2 3CLpro-IN-35 is applicable to research related to SARS-CoV-2 infection and bladder cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
SARS-CoV-2 3CLpro-IN-35 | SARS-CoV-2 3CLpro-IN-35 is a SARS-CoV-2 3CLpro inhibitor with an IC50 of 0.15 μM. SARS-CoV-2 3CLpro-IN-35 inhibits the proliferation of bladder cancer cells, exerts anti-SARS-CoV-2 activity, and exhibits low cytotoxicity in fibroblasts. SARS-CoV-2 3CLpro-IN-35 is applicable to research related to SARS-CoV-2 infection and bladder cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
